Streetbeat News

Revenues

VEEV

Veeva Systems (NYSE:VEEV) has significantly outperformed the market over the past decade, delivering an average annual return of 21.87%. A $1000 investment in VEEV 10 years ago would be worth $7,301.35 today. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 4:30 pm

CPRT

Copart (NASDAQ:CPRT) has significantly outperformed the market over the past 20 years, delivering an average annual return of 19.27%. A $1000 investment in CPRT 20 years ago would be worth $34,202.94 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 4:30 pm

ARTNA

Artesian Resources announced that the Delaware Public Service Commission (DEPSC) has approved a settlement agreement involving Artesian Water, DEPSC staff, and the Division of the Public Advocate (DPA). Additionally, DEPSC approved Artesian Water's application to implement a Distribution System Improvement Charge (DSIC) of 0.34%, effective July 1, 2024. This DSIC is subject to periodic audits by DEPSC.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:25 pm

QCOM

TSM

Analyst Ming-Chi Kuo reports that Qualcomm may become the exclusive SoC supplier for the Samsung Galaxy S25, replacing Samsung's Exynos 2500 due to lower-than-expected yield rates in Samsung's 3nm process. This shift is expected to significantly benefit Qualcomm and its exclusive supplier, TSMC.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:20 pm

LIF

Life360 has achieved a significant milestone by surpassing 2 million global paying subscriber circles for its app, demonstrating exceptional value for its members.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 4:16 pm

JNJ

LEGN

Legend Biotech's Carvykti drug is expected to see significant growth, according to Truist Securities. Analyst Asthika Goonewardene initiated coverage with a Buy rating and an $88 price target. Carvykti, developed in collaboration with Johnson & Johnson, is projected to generate over 96% year-on-year sales growth.

Portfolio Pulse from Priya Nigam

June 17, 2024 | 4:15 pm

RMD

ResMed (NYSE:RMD) has significantly outperformed the market over the past 15 years, delivering an average annual return of 17.24%. A $1000 investment in ResMed 15 years ago would be worth $10,813.40 today. The company's current market capitalization is $31 billion.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 4:00 pm

ETN

Eaton Corp (NYSE:ETN) has significantly outperformed the market over the past 5 years, delivering an average annual return of 31.15%. A $1000 investment in ETN 5 years ago would now be worth $3,907.91. The article highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 4:00 pm

DELL

NVDA

Michael Dell, Founder & CEO of Dell, discussed the company's partnership with NVIDIA and the positive impact of AI on their business during a live interview on CNBC.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 3:41 pm

NUE

Nucor (NYSE:NUE) has outperformed the market over the past 20 years, achieving an average annual return of 10.96%. A $100 investment in NUE 20 years ago would be worth $806.13 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 3:30 pm